Nike, Inc. v. New Balance Athletics, Inc.

CourtDistrict Court, D. Massachusetts
DecidedAugust 13, 2024
Docket1:23-cv-12666
StatusUnknown

This text of Nike, Inc. v. New Balance Athletics, Inc. (Nike, Inc. v. New Balance Athletics, Inc.) is published on Counsel Stack Legal Research, covering District Court, D. Massachusetts primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Nike, Inc. v. New Balance Athletics, Inc., (D. Mass. 2024).

Opinion

UNITED STATES DISTRICT COURT DISTRICT OF MASSACHUSETTS

) NIKE, INC., ) ) Plaintiff, ) ) v. ) No. 1:23-cv-12666-JEK ) NEW BALANCE ATHLETICS, INC., ) ) Defendant. ) )

MEMORANDUM AND ORDER ON DEFENDANT’S PARTIAL MOTION TO DISMISS

KOBICK, J. This is a patent infringement case involving methods for manufacturing the upper part of sneakers and other shoes. Plaintiff Nike, Inc. alleges that defendant New Balance Athletics, Inc. has infringed, and continues to infringe, nine of its patents related to those manufacturing methods. New Balance has moved to dismiss Nike’s claims with respect to three of the patents. In New Balance’s view, those patents cover shoe uppers with edges that are all knit into their final form, rather than cut from a larger knitted textile, but do not cover shoe uppers with only some of their edges knit into their final form. New Balance contends that the complaint fails to allege that its shoe uppers infringe those patents, so construed. Nike disagrees with New Balance’s view of the scope of its patented technology and contends, in any event, that it is premature to resolve the parties’ interpretive dispute on a motion to dismiss under Federal Rule of Civil Procedure 12(b)(6). The Court will not, and need not, resolve the disagreement over the scope of the technology claimed in Nike’s patents at this stage in the proceedings. Even assuming, for the sake of the motion, that Nike’s patents are limited as New Balance contends, the complaint plausibly alleges infringement. Accordingly, New Balance’s partial motion to dismiss will be denied. BACKGROUND The pertinent facts, as alleged in the complaint, are as follows. Nike is in the business of

designing, developing, marketing, and selling athletic footwear, apparel, and equipment. ECF 1, ¶ 10. The company’s research and design efforts have led to technologies and products related to athletic performance. Id. One example is Nike’s “Flyknit” technology—a method of designing and manufacturing the top part of a shoe, called the “upper,” which sits atop and is attached to the sole of the shoe. Id. ¶ 1; ECF 1-1, at 1. This upper component of a shoe “has the general shape of a foot and forms a void for receiving the foot that is accessed using the ankle opening.” Nike, Inc. v. Adidas AG, 812 F.3d 1326, 1329 (Fed. Cir. 2016). Nike has filed and obtained patents directed to its Flyknit technology. ECF 1, ¶¶ 2, 11. It alleges that New Balance—a company that likewise designs, manufactures, and sells footwear— has infringed, and continues to infringe, nine of those patents through its making and selling of shoes. Id. ¶¶ 16, 20.1 Only three of these patents—U.S. Patent No. 9,907,350 (the “’350 patent”),

U.S. Patent No. 9,918,511 (the “’511 patent”), and U.S. Patent No. 9,924,758 (the “’758 patent”)— are at issue in this motion to dismiss. These three patents concern the process for manufacturing shoe uppers. Traditionally, shoe uppers have been made by cutting the shape of the upper from a large sheet of knitted textile. See Nike, 812 F.3d at 1336-37. This method of manufacturing is called

1 The patents that Nike alleges New Balance has infringed are U.S. Patent No. 8,266,749; U.S. Patent No. 8,898,932; U.S. Patent No. 9,060,562; U.S. Patent No. 9,510,636; U.S. Patent No. 9,730,484; U.S. Patent No. 9,907,350; U.S. Patent No. 9,918,511; U.S. Patent No. 9,924,758; and U.S. Patent No. 11,707,105. ECF 1, ¶ 11. “knit to cut.” See id.; ECF 29, at 5 n.1; ECF 31, at 9. Shoe uppers can also be made by knitting a textile itself into the shape of the upper. See ECF 1-9, at 22. Under this approach, the upper is not cut from a larger piece of knitted textile, but rather comes out of the knitting machine in its final form. See id. This method of manufacturing is called “knit to shape.” See ECF 1-18, at 10. The

edges of shoe uppers that are knit into their final form, rather than made by cutting, are called “flat knit edges.” See ECF 1-9, at 26. One advantage of the knit to shape method is that it reduces materials and waste; the knit to cut method, in contrast, leaves some textile unused. See ECF 1, ¶ 1. The ’350, ’511 patent, and ’758 patents each claim uppers that use knit to shape technology. Claim 1 of the ’350 patent, for example, claims: An upper for an article of footwear, the upper comprising: a flat knit textile element having (1) flat knit edges free of surrounding textile structure such that the flat knit edges are not surrounded by textile structure from which the flat knit textile element must be removed, and (2) a plurality of apertures formed by omitting stitches in a first portion of the flat knit textile element defining a forefoot region of the upper; a non-textile element secured to a second portion of the flat knit textile element defining the heel region of the upper; and one or more strips of non-textile material secured to a third portion of the flat knit textile element on a lateral side of the upper.

ECF 1-9, at 26 (emphasis added). Claim 1 of the ’511 and ’758 patents have virtually identical language. See ECF 1-10, at 26 (’511 patent); ECF 1-11, at 26 (’758 patent). Nike alleges that several of New Balance’s shoes infringe these patents. ECF 1, ¶¶ 66, 74, 82.2 Echoing the language of the claims in the ’350, ’511, and ’758 patents, Nike further alleges

2 The specific footwear products that allegedly infringe Nike’s ’350, ’511, and ’758 patents are New Balance’s Fresh Foam More Trail v3, Fresh Foam X 1080 Unlaced, Fresh Foam X 1080 v12, Fresh Foam X Vongo v5, Fresh Foam X 1080 UNLACED, Fresh Foam X Evoz v3 Slip Resistant, FuelCell SuperComp Elite v3, FuelCell SuperComp Trainer, FuelCell MD-X, Tekela v4 Magia FG, Tekela v4 Pro FG, Tekela v4 Pro Low FG, Furon V7 Pro FG, and Furon V6+ Pro FG. ECF 1, ¶¶ 66, 74, 82. that these New Balance shoes contain “an upper for an article of footwear, the upper comprising a flat knit textile element having (1) flat knit edges free of surrounding textile structure such that the flat knit edges are not surrounded by textile structure from which the flat knit textile element must be removed, and (2) a plurality of apertures formed by omitting stitches in a first portion of the flat

knit textile element defining a forefoot region of the upper, a non-textile element secured to a second portion of the flat knit textile element defining the heel region of the upper, and one or more strips of non-textile material secured to a third portion of the flat knit textile element on a lateral side of the upper.” ECF 1, ¶ 66; see also id. ¶¶ 74 (similar), 82 (similar). Attached to Nike’s complaint are claim charts with pictures of some of New Balance’s allegedly infringing shoes, with text boxes and arrows labeling some—but not all—of the edges of the upper components of the shoes as “[f]lat knit, knit to shape edges.” See ECF 1-18, at 9-13; ECF 1-19, at 14-18; ECF 1- 20, at 9-13. Nike sent New Balance letters claiming infringement on January 31, March 3, and September 1, 2023. ECF 1, ¶¶ 13-15; ECF 1-1; ECF 1-2; ECF 1-3. On November 6, 2023, Nike

initiated this action, alleging infringement of nine of its patents, literally or under the doctrine of equivalents. ECF 1, ¶¶ 21-94. New Balance filed a partial motion to dismiss with respect to the claims related to the ’350, ’511, and ’758 patents (Counts VI, VII, and VIII) in January 2024. STANDARD OF REVIEW In evaluating a motion to dismiss under Federal Rule of Civil Procedure

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Becton, Dickinson & Co. v. Tyco Healthcare Group, LP
616 F.3d 1249 (Federal Circuit, 2010)
Rivera v. Centro Medico De Turabo, Inc.
575 F.3d 10 (First Circuit, 2009)
Amgen Inc. v. F. Hoffmann-La Roche Ltd.
580 F.3d 1340 (Federal Circuit, 2009)
Ocasio-Hernandez v. Fortuno-Burset
640 F.3d 1 (First Circuit, 2011)
Southwall Technologies, Inc. v. Cardinal Ig Company
54 F.3d 1570 (Federal Circuit, 1995)
Freeman v. Town of Hudson
714 F.3d 29 (First Circuit, 2013)
Nike, Inc. v. Adidas Ag
812 F.3d 1326 (Federal Circuit, 2016)
Lifetime Industries, Inc. v. Trim-Lok, Inc.
869 F.3d 1372 (Federal Circuit, 2017)
Nalco Company v. Chem-Mod, LLC
883 F.3d 1337 (Federal Circuit, 2018)
Cortes-Ramos v. Martin-Morales
956 F.3d 36 (First Circuit, 2020)
Bot M8 LLC v. Sony Corporation of America
4 F.4th 1342 (Federal Circuit, 2021)
Douglas v. Hirshon
63 F.4th 49 (First Circuit, 2023)

Cite This Page — Counsel Stack

Bluebook (online)
Nike, Inc. v. New Balance Athletics, Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/nike-inc-v-new-balance-athletics-inc-mad-2024.